Gyorgy Kerekes
Moricz Zs Str
Debrecen, HB 4032, Hungary
Debrecen, HB 4032, Hungary
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 33 publications
Effects of Tofacitinib Therapy on Circulating Tumour-Associated Antigens and Their Relationship with Clinical, Laboratory and Vascular Parameters in Rheumatoid Arthritis.
Journal: Biomolecules
Published: March 26, 2025
Steady-State Versus Chemotherapy-Based Stem Cell Mobilization in Multiple Myeloma: A Single-Center Study to Analyze Efficacy and Safety.
Journal: Journal of hematology
Published: February 26, 2024
Natural Autoantibodies in Biologic-Treated Rheumatoid Arthritis and Ankylosing Spondylitis Patients: Associations with Vascular Pathophysiology.
Journal: International journal of molecular sciences
Published: February 14, 2024
Eculizumab Treatment of Massive Hemolysis Occurring in a Rare Co-Existence of Paroxysmal Nocturnal Hemoglobinuria and Myasthenia Gravis.
Journal: Hematology reports
Published: February 05, 2024
Atherosclerosis in autoimmune rheumatic diseases.
Journal: European journal of internal medicine
Published: July 21, 2023
One Step Back from Bedside to the Bench-How Do Different Arterial Stiffness Parameters Behave in Relation to Peripheral Resistance?
Journal: Diagnostics (Basel, Switzerland)
Published: July 20, 2023
Effect of tofacitinib therapy on angiotensin converting enzyme activity in rheumatoid arthritis.
Journal: Frontiers in medicine
Published: May 22, 2023
Effects of 1-year tofacitinib therapy on angiogenic biomarkers in rheumatoid arthritis.
Journal: Rheumatology (Oxford, England)
Published: March 10, 2023
Effects of One-Year Tofacitinib Therapy on Lipids and Adipokines in Association with Vascular Pathophysiology in Rheumatoid Arthritis.
Journal: Biomolecules
Published: September 10, 2022
Effects of tofacitinib therapy on arginine and methionine metabolites in association with vascular pathophysiology in rheumatoid arthritis: A metabolomic approach.
Journal: Frontiers in medicine
Published: August 04, 2022
EULAR recommendations for cardiovascular risk management in rheumatic and musculoskeletal diseases, including systemic lupus erythematosus and antiphospholipid syndrome.
Journal: Annals of the rheumatic diseases
Published: October 23, 2021
Last Updated: 09/26/2026